New Drug for Fibromyalgia

Fibromyalgia is a disorder characterized by widespread chronic pain and an extreme sensitivity to touch. Symptoms of fibromyalgia can vary from joint stiffness, sleep disturbance and incapacitating fatigue, to difficulty breathing or swallowing and abnormal cognitive function and motor activity. To address this debilitating disorder, Forest Laboratories Inc. and Cypress Bioscience Inc. have partnered to create a new drug to treat fibromyalgia call milnacipran.

The following article discusses a late-stage, Phase III study on the fibromyalgia drug milnacipran. According to the article, the drug has been shown to positively improve pain symptoms related to the disorder and is currently under review by the Food and Drug Administration (FDA). The article also talks about a delay in the review, but gives hope to a full analysis of the drug in the coming weeks. The article also gives information on Forest Laboratories and Cypress Bioscience.

Forest, Cypress see positive study on pain drug












Return to:

Social Security Disability Secrets

Social Security Disability Benefits Questions



Additional Posts

I Heard That Social Security Disability Will Deny You Several Times
When should you get a Representative for Social Security Disability or SSI?
Disability Determination for Social Security Disability Benefits
Winning your Social Security Disability
Applying for disability with fibromyalgia
Social Security Disability SSI and Chronic pain
Chronic pain information